DOI:
10.1055/s-00000058
Planta Medica
LinksClose Window
References
Xu JH, Liu DY, Niu HL, Zhu GF, Xu YW, Ye DL, Li J, Zhang QL.
Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.
J Exp Clin Canc Res 2017;
36: 19
We do not assume any responsibility for the contents of the web pages of other providers.